U.S., May 27 -- ClinicalTrials.gov registry received information related to the study (NCT07606716) titled 'Factors Determining the Rate of Adoption of Pharmaceutical Recommendations by Patients in Primary Care Following a Medication Review by a Pharmacist' on May 19.

Brief Summary: Polypharmacy is a major and growing public health concern, associated with increased risks of adverse drug events, drug interactions, and hospitalizations. Medication reviews (MedRev), defined as structured evaluations of patients' medications aiming to optimize drug use and improve health outcomes, are increasingly promoted to address these challenges. In Belgium, a reimbursed MedRev service has been implemented in community pharmacies since 2023, involving co...